Possible mechanism of the hypotensive action of 2,6-dichlorobenzylidene aminoguanidine: evidence for central noradrenaline receptor stimulation.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism; D002540:Cerebral Cortex / Q000032:analysis; D002746:Chlorpromazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006146:Guanidines / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006614:Hindlimb / Q000187:drug effects; D007031:Hypothalamus / Q000032:analysis; D007097:Imines / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis / Q000502:physiology; D051381:Rats; D011950:Receptors, Cholinergic; D011955:Receptors, Drug / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013141:Spiro Compounds / Q000494:pharmacology; D013268:Stimulation, Chemical
D000959:Antihypertensive Agents; D002395:Catecholamines; D006146:Guanidines; D007097:Imines; D008781:Methyltyrosines; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013141:Spiro Compounds; D012701:Serotonin; D002746:Chlorpromazine; D009638:Norepinephrine